Mouse immunoglobulin D: messenger RNA and genomic DNA sequences

Science
P W TuckerF R Blattner

Abstract

The molecular structure of a mouse immunoglobulin D from a plasmacytoma tumor and that of the normal mouse gene coding for immunoglobulin D are presented. The DNA sequence results indicate an unusual structure for the tumor delta chain in two respects: (i) Only two constant (C) region domains, termed C delta 1 and C delta 3 by homology considerations, are found; the two domains are separated by an unusual hinge region C delta H that lacks cysteine residues and thus cannot provide the covalent cross-links between heavy chains typically seen in immunoglobulins. The two domains and hinge are all coded on separate exons. (ii) At the carboxyl end of the delta chain there is a stretch of 26 amino acids that is coded from an exon located 2750 to 4600 base pairs downstream from the rest of the gene. Analogy with immunoglobulin M suggests that this distally coded segment C delta DC may have a membrane-binding function; however, it is only moderately hydrophobic. A fifth potential exon (C delta AC), located adjacent to the 3' (carboxyl) end of C delta 3, could code for a stretch of 49 amino acids. The tumor's expression of the delta gene may be aberrant, but the simplest interpretation would be that this tumor expresses one of the severa...Continue Reading

References

Jan 1, 1977·Immunological Reviews·E S Vitetta, J W Uhr
Dec 21, 1978·Nature·J G Seidman, P Leder
Jun 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·M KehryL E Hood
Jul 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·E E MaxP Leder
Jun 1, 1979·European Journal of Immunology·A BargellesiM Ferrarini
Oct 26, 1976·Biochimica Et Biophysica Acta·C Tanford, J A Reynolds
Oct 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·R BreathnachP Chambon
Dec 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·L C Lin, F W Putnam
Jul 1, 1977·The Journal of Experimental Medicine·J F KearneyA R Lawton
Jul 1, 1979·The Journal of Experimental Medicine·S J Black, L A Herzenberg
Jan 1, 1977·Immunological Reviews·H L Spiegelberg
Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·C Brack, S Tonegawa
Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·R L Jilka, S Pestka
Jan 1, 1977·Journal of Supramolecular Structure·G Guidotti
Sep 1, 1976·The Journal of Experimental Medicine·J W Goding, J E Layton
Sep 16, 1976·Nature·N J Proudfoot, G G Brownlee
Aug 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·M Tomita, V T Marchesi
Sep 19, 1975·Science·E S Vitetta, J W Uhr
Aug 1, 1976·The Journal of Experimental Medicine·K OkumuraL A Herzenberg
Jun 1, 1969·The Journal of Experimental Medicine·K RajewskyN K Jerne
Dec 13, 1974·Nature·E R Abney, R M Parkhouse
Aug 25, 1974·Journal of Molecular Biology·J P Segrest, R J Feldmann
Apr 2, 1974·Archives of Biochemistry and Biophysics·H B Bull, K Breese
May 1, 1980·The Journal of Experimental Medicine·V T OiL A Herzenberg
Jan 1, 1980·Methods in Enzymology·A M Maxam, W Gilbert
Apr 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·J Rogers, R Wall
Sep 19, 1980·Science·C P LiuF R Blattner
May 1, 1980·The Journal of Experimental Medicine·L A HerzenbergL A Herzenberg
Jan 10, 1980·Nature·M R LernerJ A Steitz
Apr 25, 1980·Biochimica Et Biophysica Acta·K W Olsen

❮ Previous
Next ❯

Citations

Dec 1, 1982·Molecular Immunology·R R Pollock, M F Mescher
Dec 1, 1987·Veterinary Immunology and Immunopathology·K L Knight, R S Becker
Dec 12, 2003·Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology·Katherine Belov, Lars Hellman
May 21, 1999·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·A TakeuchiK Oda
Aug 14, 1999·Scandinavian Journal of Immunology·I HordvikB Krossøy
Dec 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·J F MushinskiP W Tucker
Oct 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·F W PutnamL C Lin
Dec 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·J Rogers, R Wall
Dec 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·P W TuckerF R Blattner
Mar 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·K W MooreL E Hood
Jul 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·J W Goding, A W Harris
May 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·S G DevareS A Aaronson
Dec 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·F T LiuD H Katz
May 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·N TakahashiF W Putnam
May 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·M R KnappF Blattner
Nov 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·U Storb, B Arp
Jul 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·A C GilliamP W Tucker
Oct 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·S M TammaR F Coico
Aug 1, 1984·The Journal of Experimental Medicine·D Yuan, P W Tucker
Oct 11, 1983·Nucleic Acids Research·M KomaromyR Wall
Jan 11, 1984·Nucleic Acids Research·V Paetkau
Aug 1, 2006·Proceedings of the National Academy of Sciences of the United States of America·Yaofeng ZhaoLennart Hammarström
Apr 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·M WilsonG W Warr
Mar 19, 2011·Developmental and Comparative Immunology·Eva-Stina EdholmMelanie Wilson
Dec 25, 2010·Developmental and Comparative Immunology·Yi SunYaofeng Zhao
May 1, 1986·Immunology Today·J E Calvert
Jan 1, 1982·Annals of the New York Academy of Sciences·H P Kocher, H L Spiegelberg
Jan 1, 1982·Annals of the New York Academy of Sciences·F W PutnamB Debuire
Jan 1, 1982·Immunological Reviews·A CoutinhoS Pettersson
Oct 1, 1982·European Journal of Immunology·R G Vasilov, H L Ploegh
Aug 2, 2005·Developmental and Comparative Immunology·Yaofeng ZhaoRobert Aitken
Jan 1, 1982·Differentiation; Research in Biological Diversity·H Naora, N J Deacon
Feb 2, 1984·Nature·F R Blattner, P W Tucker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
K W MooreL Hood
Proceedings of the National Academy of Sciences of the United States of America
E A Robinson, E Appella
© 2021 Meta ULC. All rights reserved